Literature DB >> 22933183

Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study.

Teruki Miyake1, Teru Kumagi, Masashi Hirooka, Shinya Furukawa, Mitsuhito Koizumi, Yoshio Tokumoto, Teruhisa Ueda, Shin Yamamoto, Masanori Abe, Kohichiro Kitai, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able to easily identify high-risk NAFLD patients so that intervention can begin at an earlier stage. We sought to identify the predictive factors for NAFLD onset.
METHODS: In a community-based, longitudinal design, the records of 6,403 Japanese subjects were reviewed to identify those meeting the criteria for NAFLD onset. Univariate and multivariate logistic regression analyses were used to identify predictive factors for NAFLD onset. The accuracy of different models was evaluated according to their areas under the receiver operating characteristic curves. Comparative risk analysis was performed using the Kaplan-Meier method.
RESULTS: Multivariate analysis of 400 subjects who met the criteria for the onset of NAFLD during the observation period confirmed that body mass index (BMI) at baseline was the most useful predictive factor for NAFLD onset in both sexes. Cutoff levels of BMI for NAFLD onset were estimated at 23 kg/m2 for men and 22.2 kg/m2 for women. The cumulative onset rate of NAFLD was significantly higher in the high BMI group than in the low BMI group in both sexes (P < 0.001).
CONCLUSION: BMI was confirmed as the most useful predictive factor for NAFLD onset in both sexes; its cutoff levels were similar to those recommended by the World Health Organization for helping to prevent metabolic disease. An accurate BMI cutoff level will enable clinicians to identify subjects at risk for NAFLD onset.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22933183     DOI: 10.1007/s00535-012-0650-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  30 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background.

Authors:  Sei-Ichiro Kojima; Norihito Watanabe; Makoto Numata; Tetsuhei Ogawa; Shohei Matsuzaki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

3.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

4.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  Non-alcoholic steatohepatitis in type 2 diabetes mellitus.

Authors:  Parijat Gupte; Deepak Amarapurkar; Subhash Agal; Rajiv Baijal; Pramod Kulshrestha; Snehansu Pramanik; Nikhil Patel; Aruna Madan; Anjali Amarapurkar
Journal:  J Gastroenterol Hepatol       Date:  2004-08       Impact factor: 4.029

6.  Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance.

Authors:  G Donati; B Stagni; F Piscaglia; N Venturoli; A M Morselli-Labate; L Rasciti; L Bolondi
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

7.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Chisato Nagata; Jun Takeda; Hiroshi Sarui; Yutaka Kawahito; Naohisa Yoshida; Atsushi Suetsugu; Takahiro Kato; Junichi Okuda; Kazunori Ida; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

8.  Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study.

Authors:  Hyeon Chang Kim; Chung Mo Nam; Sun Ha Jee; Kwang Hyub Han; Dae Kyu Oh; Il Suh
Journal:  BMJ       Date:  2004-03-17

9.  Nonalcoholic steatohepatitis with improved hepatic fibrosis after weight reduction.

Authors:  Keita Fujikawa; Kazuyuki Ohata; Takuya Honda; Seiji Miyazoe; Tatsuki Ichikawa; Hiroki Ishikawa; Keisuke Hamasaki; Kazuhiko Nakao; Kan Toriyama; Katsumi Eguchi
Journal:  Intern Med       Date:  2004-04       Impact factor: 1.271

10.  Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study.

Authors:  Ji Cheol Bae; Eun Jung Rhee; Won Young Lee; Se Eun Park; Cheol Young Park; Ki Won Oh; Sung Woo Park; Sun Woo Kim
Journal:  Diabetes Care       Date:  2011-01-28       Impact factor: 19.112

View more
  27 in total

1.  Body mass index and nonalcoholic fatty liver disease.

Authors:  Shih-Wei Lai; Kuan-Fu Liao
Journal:  J Gastroenterol       Date:  2013-01-17       Impact factor: 7.527

2.  Reply to the letter by Lai et al. regarding "body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal study".

Authors:  Teruki Miyake; Teru Kumagi; Shinya Furukawa; Masanori Abe; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  J Gastroenterol       Date:  2013-01-30       Impact factor: 7.527

3.  Short sleep duration reduces the risk of nonalcoholic fatty liver disease onset in men: a community-based longitudinal cohort study.

Authors:  Teruki Miyake; Teru Kumagi; Shinya Furukawa; Masashi Hirooka; Keitarou Kawasaki; Mitsuhito Koizumi; Yasuhiko Todo; Shin Yamamoto; Yoshio Tokumoto; Yoshio Ikeda; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2014-08-13       Impact factor: 7.527

4.  Biphasic effect of alcohol intake on the development of fatty liver disease.

Authors:  Hirokazu Takahashi; Masafumi Ono; Hideyuki Hyogo; Chika Tsuji; Yoichiro Kitajima; Naofumi Ono; Takahisa Eguchi; Kazuma Fujimoto; Kazuaki Chayama; Toshiji Saibara; Keizo Anzai; Yuichiro Eguchi
Journal:  J Gastroenterol       Date:  2015-03-03       Impact factor: 7.527

5.  The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD.

Authors:  C L Gentile; T L Weir; K A Cox-York; Y Wei; D Wang; L Reese; G Moran; A Estrada; C Mulligan; M J Pagliassotti; M T Foster
Journal:  Adipocyte       Date:  2015-01-14       Impact factor: 4.534

6.  A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study.

Authors:  Michelle T Long; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Jiantao Ma; Rohit Loomba; Raymond T Chung; Emelia J Benjamin
Journal:  Liver Int       Date:  2018-03-12       Impact factor: 5.828

7.  Significance of exercise in nonalcoholic fatty liver disease in men: a community-based large cross-sectional study.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Shinya Furukawa; Keitarou Kawasaki; Mitsuhito Koizumi; Yasuhiko Todo; Shin Yamamoto; Hiroaki Nunoi; Yoshio Tokumoto; Yoshio Ikeda; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2014-04-21       Impact factor: 7.527

8.  Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes.

Authors:  Minoru Tomizawa; Yuji Kawanabe; Fuminobu Shinozaki; Sumihiko Sato; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi
Journal:  Biomed Rep       Date:  2014-07-01

9.  The Correlation Between Obesity-Related Diseases and Non-alcoholic Fatty Liver Disease in Women in the Pre-operative Evaluation for Bariatric Surgery Assessed by Transient Hepatic Elastography.

Authors:  Fernando de Barros; Sérgio Setúbal; José Manoel Martinho; Nathalie Carvalho Leite; Thais Guaraná; Ana Beatriz Soares Monteiro; Cristiane A Villela-Nogueira
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

10.  RORα decreases oxidative stress through the induction of SOD2 and GPx1 expression and thereby protects against nonalcoholic steatohepatitis in mice.

Authors:  Yong-Hyun Han; Hyeon-Ji Kim; Eun-Jin Kim; Kyu-Seo Kim; Suckchang Hong; Hyeung-Geun Park; Mi-Ock Lee
Journal:  Antioxid Redox Signal       Date:  2014-04-10       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.